Seres Therapeutics
NASDAQ: MCRBCambridge, US · 3 known investors
Seres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome. The company pioneered the development and FDA approval of VOWST, an oral live biotherapeutic.
Founders & leadership
MH
Matthew HennPresident and Chief Scientific Officer